Surgical Sutures Market (By Product: Automated Suturing Devices, Sutures; By Type: Monofilaments, Multifilament; By Application: Cardiovascular surgery, Orthopedic surgery, Gynecological surgery, Opthalmic surgery, Cosmetic and plastic surgery, General surgery, Others; By End User: Hospitals, Clinics, Ambulatory Surgical Centres, Emergency Medical Services, Veterinary Hospitals, Veterinary Clinics; By Raw Material)- Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2022-2030

The global Surgical Sutures market size was estimated at USD 4.5 billion in 2021 and is expected to surpass around USD 7.2 billion by 2030 and poised to grow at a compound annual growth rate (CAGR) of 5.36% during the forecast period 2022 to 2030.

Key Takeaways:

  • By type, the absorbable segment accounted market share of 55.5% in 2021.
  • By filament, the multifilament segment has had highest revenue share of 54% in 2021.
  • By application, the others segment held 36% revenue share in 2021. However, the cardiovascular surgery segment hit second-largest market share in 2021.
  • The North America region accounted 42% revenue share in 2021.

The market growth can be attributed to a rise in surgical procedures due to an increasing number of cardiac diseases and orthopedic injuries, which occur due to the increasing geriatric population as well as the rising number of accidents. The lifestyle changes, growing healthcare expenditure, favorable reimbursement scenarios, and government support to improve the healthcare infrastructure are also significant factors contributing to the growth of the market.

Although the market may have witnessed a certain lag in terms of revenue during the pandemic, it is recovering at a decent pace and is expected to grow considerably during the forecast period. The lockdowns and changes in healthcare priorities have majorly affected the market in terms of demand. While the restrictions also affected the supply chain with limited manufacturing activities, travel restrictions disrupted the supply of raw materials as well as the final product.

However, with the key players focusing on technological aspects to overcome similar challenges in the future, the market is expected to flourish and gain back its pre-COVID growth rate. Moreover, considering that the COVID-19 affected population is at a higher risk of developing diseases, there might be a rise in cardiac diseases among individuals. This may further lead to the surged demand for surgical sutures.

The market was negatively affected during the pandemic due to the postponement of many surgical procedures in response to control the spread of the COVID-19 virus. However, the market has begun to recover and the market leaders and healthcare professionals involved in providing the surgery service are focusing on technological advancement in order to optimize the workflow and carry out a higher number of surgeries as compared to pre-pandemic days.

Report Scope of the Surgical Sutures Market

Report Coverage

Details

Market Size in 2022

USD 4.74 Billion

Market Size by 2030

USD 7.2 Billion

Growth Rate from 2022 to 2030

CAGR of 5.36%

Base Year

2021

Forecast Period

2022 to 2030

Segments Covered

Product, Type, Raw Material, By Application, End User, Geography

Companies Mentioned

Advanced Medical Solutions Group plc (UK), Internacional Farmacéutica S.A. de C.V.(Mexico), Medtronic Plc (Ireland), Johnson & Johnson (US), B. Braun Melsungen (Germany), Smith & Nephew (UK), Deme TECH Corporation (US), Surgical Specialties Corporation (US), Boston Scientific Corporation (US), Peters Surgical (France), Dolphin Sutures (India), Derma Sciences (US), CONMED Corporation (US), Sutcon Sutures (Indonesia), Stryker Corporation (US), Healthium MedTech (India), Zimmer Biomet (US), GPC Medical (India), Lotus Surgicals (India), Vital Sutures (US), Sutumed CPT Sutures (India), Unilene (India), Mellon Medical B.V.(Netherlands), Riverpoint Medical (US)

 

Surgical Sutures Market Dynamics

Drivers :

According to the WHO 2016 Report, the estimated mean global surgical rate was 4,469 operations per 100,000 people per year, with road accidents and associated trauma being the major cause of surgical treatment. According to the EC Factsheet 2017, globally, there are around 174 fatalities per million population every year. Furthermore, WHO data estimates that around 1.3 million people die each year on the roads. For every road accident-related death, there are 20 other persons who sustain non-fatal injuries that often require surgical intervention.

The aging population is at a higher risk of chronic diseases and conditions and requires frequent surgeries. Adults aged 65 and above account for a large fraction of surgeries performed in the US. The rapid growth in the aging population and the growing incidence of various chronic diseases are expected to significantly drive the number of surgeries performed globally. Furthermore, by 2030, noncommunicable diseases (NCDs) are projected to account for more than one-half of the disease burden in low-income countries and more than three-fourths in middle-income countries. In the geriatric population, NCDs account for more than 87% of the burden in low, middle, and high-income countries. The high prevalence of chronic diseases, especially among the geriatric population, will considerably boost the number of surgical treatment procedures conducted and thus drive the demand and use of surgical sutures.

In recent years, the number of cosmetic and aesthetic procedures has risen due to the growing geriatric population, rising disposable income, availability of advanced technologies, and growing procedural safety. The popularity of these procedures across the globe presents a significant growth opportunity to players in the surgical sutures market. According to the American Society of Plastic Surgeons (ASPS), from 2016 to 2017, the number of cosmetic surgeries in the US grew by 1%, with 17.9 million surgical and minimally invasive cosmetic procedures performed in 2017. The trend was similar in Europe, with an increase of ~134% in Italy, ~0.5% in France, and ~9% in Germany.

Restrains :

Topical skin adhesives, hemostatic and sealing agents (such as fibrin sealants, surgical sealants, gelatin-based sealants, human fibrinogen, and thrombin fleeces), and wound closure devices (such as stapling devices, ligating clips, and wound closure strips) are some alternatives to surgical sutures.

These alternative products are associated with certain advantages. For instance, stapling is quicker than suturing. Furthermore, the area requiring suturing is an important factor for determining the selection of material. In the case of head injuries, a stapler can work quickly, saving time and blood loss, thus making it a preferred choice over sutures. Similarly, small incisions and wounds (less than 10 cm) can be closed by tissue adhesives in a relatively painless procedure for pediatric patients without the need for removal, as in the case of sutures. Wound closure strips and tapes can also be used to close smaller lacerations. These products provide better closure and prognosis in the case of elderly patients, especially those with frail skin. Due to their efficiency and benefits over surgical sutures, the availability of alternatives is a key restraint for surgical suture market.

Opportunities:

The Lancet Commission Report, published in April 2015, estimated that five billion people do not have access to safe and affordable surgical care. As many as 143 million additional surgical procedures are needed in low- and middle-income countries (LMICs) each year to reduce the mortality rate and decrease disability. Of the 313 million procedures performed globally every year, only 6% occur in the poorest countries, which are home to one-third of the world’s population.

A number of international communities as well as LMIC governments have undertaken initiatives to reduce this gap between the surgeries needed and performed. In developing countries such as India, health insurance coverage has grown tremendously by 23.8% from 2014 to 2017. Currently, 30% of the Indian population has health insurance coverage. The Universal Health Cover (UHC), Mexico’s health reform, has improved access, equity, and use of services, which has resulted in a substantial increase in surgical volumes in the country at an average rate of 23% per year.

It is estimated that against the backdrop of the growing demand for healthcare and associated infrastructure, there will be an increase in initiatives and efforts to resolve this situation over the coming years. This will result in a corresponding increase in both access to and adoption of effective treatment modalities for a number of ailments—globally, but particularly in LMICs—thereby driving the growth of associated markets, such as surgical sutures.

Product Insights

On the basis of product, the market of suture threads has experienced the maximum growth due to the huge demand in the health care industry. the use of surgical threads in order to close a wound has been considered as the first choice in many healthcare sectors due to their cost-effective features which enables a common man to opt for such products.

Automated sharing devices on the other hand, impose an additional cost on the treatment procedure which makes this technology unaffordable for the common people. Surgical sutures are used extensively in the gynecological procedures which facilitates easy healing of wound. Automated suturing devices require a lesser amount of time to complete the surgical procedure.

Type Insights

On the basis of type, the segment of multifilament as acquired a larger market share as compared to its competitors due to the rapidly increasing complex surgeries which have taken place all over the world. The huge number of people belonging to the geriatric population results into a number of complex surgical procedures which has helped this market to record a considerable revenue over a period of time.

The additional benefit of wound healing which is provided by this material behaves as a major growth factor for the market. The reimbursement facilities that are provided by the insurance companies encourage the use of such advanced materials by the health care industry.

Application Insights

The others segment dominated the market for surgical sutures and held a revenue share of over 36% in 2021. The cardiovascular surgery segment held the second-largest revenue share in 2021. This is owing to the high incidence of cardiac diseases, the presence of sufficient experts in the field, supportive reimbursement scenarios, and advancement in diagnostics. This is leading to a significant rise in the number of cardiac surgeries, which in turn, is leading to an increase in the demand for surgical sutures over the forecast period.

The orthopedic surgery segment emerged as the third-largest application segment in 2021 and is expected to witness lucrative growth over the forecast period. This is due to the growing number of road accidents that are leading to a rise in the number of orthopedic injuries. According to the U.S. Department of Transportation, an estimated 20,160 people lost their lives in motor vehicle accidents in the first half of 2021.

End User Insights

On the basis of end user, the segment of hospitals has shown the fastest growth resulting from the huge number of patients that present themselves to a hospital in the event of an accident or a major pathological disorder. Surgical procedures are usually carried out in a hospital set-up where the presence of other multiple facilities helps the entire process to be carried out smoothly.

Regional Insights

The North American region dominated the market for surgical sutures in 2021 with a revenue share of over 42% owing to the presence of local and key players, high cost of sutures as compared to other regions, supportive reimbursement scenario, rising government programs, and developed healthcare infrastructure. Technological advancements and high domestic income are also the key factors that are contributing to the large revenue share of North America.

Asia Pacific is expected to witness the fastest growth during the forecast period. This is due to the growing geriatric population base that is more likely to go under surgery and increase in government spending on the healthcare infrastructure to meet the unmet needs in this region. China, India, and Japan are amongst the major markets in the Asia Pacific region. Increasing medical tourism in countries like India, Singapore, and Malaysia is another major factor that is driving the market towards exponential growth in this region.

Some of the prominent players in the Surgical Sutures Market include:

  • Advanced Medical Solutions Group plc (UK)
  • Internacional Farmacéutica S.A. de C.V.(Mexico)
  • Medtronic Plc (Ireland)
  • Johnson & Johnson (US)
  • B. Braun Melsungen (Germany)
  • Smith & Nephew (UK)
  • Deme TECH Corporation (US)
  • Surgical Specialties Corporation (US)
  • Boston Scientific Corporation (US)
  • Peters Surgical (France)
  • Dolphin Sutures (India)
  • Derma Sciences (US)
  • CONMED Corporation (US)
  • Sutcon Sutures (Indonesia)
  • Stryker Corporation (US)
  • Healthium MedTech (India)
  • Zimmer Biomet (US)
  • GPC Medical (India)
  • Lotus Surgicals (India)
  • Vital Sutures (US)
  • Sutumed
  • CPT Sutures (India)
  • Unilene (India)
  • Mellon Medical B.V.(Netherlands)
  • Riverpoint Medical (US)

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Nova one advisor, Inc. has segmented the global Surgical Sutures market

By Product

  • Automated Suturing Devices
    • Disposable Automated Suturing Devices
    • Reusable Automated Suturing Devices
  • Sutures
    • Natural Sutures
    • Synthetic Sutures
      • Vicryl Sutures
      • Monocryl Sutures
      • Polydioxanone Sutures
      • Polyglycolic Sutures
      • Others
    • Nylon Sutures
    • Prolene Sutures
    • Stainless Steel Sutures
    • Others
    • Absorbable Sutures
    • Nonabsorbable Sutures

By Type

  • Monofilaments
  • Multifilament

By Raw Material

  • Polyglycolic Acid Absorbable Surgical Sutures
  • Polyglactin Absorbable Surgical Sutures
  • Catgut Absorbable Surgical Sutures
  • Poliglecaprone Absorbable Surgical Sutures
  • Polydioxanone Absorbable Surgical Sutures
  • Polypropylene Non-Absorbable Surgical Sutures
  • Nylon (Poylamide) Non-Absorbable Surgical Sutures
  • Polyester Non-Absorbable Surgical Sutures
  • Polyvinylidene Fluoride (PVDF)
  • Non-Absorbable Surgical Sutures
  • Silk Non-Absorbable Surgical Sutures
  • Stainless Steel Non-Absorbable Surgical Sutures

By Application

  • Cardiovascular surgery
  • Orthopedic surgery
  • Gynecological surgery
  • Opthalmic surgery
  • Cosmetic and plastic surgery
  • General surgery
  • Others

<span style="font-size: 12.0pt; line-height: 115%; mso-fareast-font-family: 'Times New Roman'; mso-